Fig. 2From: MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancerExamples of MYC and MET status by FISH. a Normal MYC; b amplified MYC; c normal MET; d one of four amplified MET tumorsBack to article page